![Pharmacokinetic profiles of lopinavir (a) and low-dose ritonavir (b) in... | Download Scientific Diagram Pharmacokinetic profiles of lopinavir (a) and low-dose ritonavir (b) in... | Download Scientific Diagram](https://www.researchgate.net/profile/Laura-Else/publication/51817889/figure/fig1/AS:305968698150912@1449960030155/Pharmacokinetic-profiles-of-lopinavir-a-and-low-dose-ritonavir-b-in-HIV-infected.png)
Pharmacokinetic profiles of lopinavir (a) and low-dose ritonavir (b) in... | Download Scientific Diagram
![Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial - The Lancet HIV Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial - The Lancet HIV](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b6e8ea9c-193f-41b5-8409-0f469e347a20/gr1_lrg.gif)
Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial - The Lancet HIV
![Reduced dose darunavir/ritonavir effective and safe for people switching while virally suppressed | aidsmap Reduced dose darunavir/ritonavir effective and safe for people switching while virally suppressed | aidsmap](https://www.aidsmap.com/sites/default/files/styles/aidsmap_social_default/public/2018-07/reduced-dose-darunavir-ritonavir-effective-and-safe-for-people-switching-while-virally-suppressed.jpg?itok=ZWEWUWgd)
Reduced dose darunavir/ritonavir effective and safe for people switching while virally suppressed | aidsmap
![Lower-dose lopinavir/ritonavir reduces side-effects, maintains viral control in Thai children | aidsmap Lower-dose lopinavir/ritonavir reduces side-effects, maintains viral control in Thai children | aidsmap](https://www.aidsmap.com/sites/default/files/styles/aidsmap_social_default/public/2013-07/lower-dose-lopinavir-ritonavir-reduces-side-effects-maintains-viral-control-in-thai-children.jpg?itok=zu4wqrf4)
Lower-dose lopinavir/ritonavir reduces side-effects, maintains viral control in Thai children | aidsmap
Lopinavir–ritonavir super-boosting in young HIV-infected children on rifampicin-based tuberculosis therapy compared with lopin
![Association of lopinavir concentrations with plasma lipid or glucose concentrations in HIV-infected South Africans: a cross sectional study | AIDS Research and Therapy | Full Text Association of lopinavir concentrations with plasma lipid or glucose concentrations in HIV-infected South Africans: a cross sectional study | AIDS Research and Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1742-6405-9-32/MediaObjects/12981_2012_Article_253_Fig1_HTML.jpg)
Association of lopinavir concentrations with plasma lipid or glucose concentrations in HIV-infected South Africans: a cross sectional study | AIDS Research and Therapy | Full Text
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KALETRA safely and effec
![Once-daily reduced dose darunavir/ritonavir (400 mg/100 mg) is non-inferior to twice-daily lopinavir/ritonavir in South African switch study | HTB | HIV i-Base Once-daily reduced dose darunavir/ritonavir (400 mg/100 mg) is non-inferior to twice-daily lopinavir/ritonavir in South African switch study | HTB | HIV i-Base](https://i-base.info/htb/wp-content/uploads/2018/06/LOGO-IAS-2018-combined.png)
Once-daily reduced dose darunavir/ritonavir (400 mg/100 mg) is non-inferior to twice-daily lopinavir/ritonavir in South African switch study | HTB | HIV i-Base
Randomised Pharmacokinetic Trial of Rifabutin with Lopinavir/Ritonavir-Antiretroviral Therapy in Patients with HIV-Associated Tuberculosis in Vietnam | PLOS ONE
![Long-Term Treatment with Lopinavir-Ritonavir Induces a Reduction in Peripheral Adipose Depots in Mice | Antimicrobial Agents and Chemotherapy Long-Term Treatment with Lopinavir-Ritonavir Induces a Reduction in Peripheral Adipose Depots in Mice | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.00625-06/asset/04d6a25e-594a-4f4a-9306-f3e2e28dd450/assets/graphic/zac0120661920001.jpeg)
Long-Term Treatment with Lopinavir-Ritonavir Induces a Reduction in Peripheral Adipose Depots in Mice | Antimicrobial Agents and Chemotherapy
![Experimental COVID-19 Therapy Combination Lopinavir/Ritonavir Is Implicated in a Complicated Set of Drug-Drug Interactions - Anesthesia Patient Safety Foundation Experimental COVID-19 Therapy Combination Lopinavir/Ritonavir Is Implicated in a Complicated Set of Drug-Drug Interactions - Anesthesia Patient Safety Foundation](https://www.apsf.org/wp-content/uploads/ddi/2020/lopinavir-ritonavir.jpg)
Experimental COVID-19 Therapy Combination Lopinavir/Ritonavir Is Implicated in a Complicated Set of Drug-Drug Interactions - Anesthesia Patient Safety Foundation
![Lopinavir/ritonavir 'not effective' for patients hospitalised with COVID-19, third set of RECOVERY trial results show - The Pharmaceutical Journal Lopinavir/ritonavir 'not effective' for patients hospitalised with COVID-19, third set of RECOVERY trial results show - The Pharmaceutical Journal](https://pharmaceutical-journal.com/wp-content/uploads/2021/01/kaletra-spl-20-927x617.jpg)